**Core Concept**
Langerhans cell histiocytosis (LCH) is a rare disorder characterized by the proliferation of Langerhans cells, a type of dendritic cell involved in the immune response. This condition can manifest as various clinical syndromes, including unifocal and multifocal forms, with the latter often presenting with systemic involvement.

**Why the Correct Answer is Right**
The presence of Langerhans giant cells in the biopsy specimen confirms the diagnosis of LCH. The most commonly associated marker with this condition is CD1a, a surface glycoprotein expressed on the surface of Langerhans cells. CD1a plays a crucial role in the presentation of lipid antigens to T-cells, facilitating the immune response. The detection of CD1a using immunohistochemistry or flow cytometry is essential for diagnosing LCH.

**Why Each Wrong Option is Incorrect**
**Option B:** S-100 protein is a marker associated with melanocytic lesions and is not specific for Langerhans cell histiocytosis.
**Option C:** CD68 is a marker expressed on the surface of monocytes and macrophages, but it is not specific for Langerhans cells.
**Option D:** HLA-DR is a marker associated with antigen presentation, but it is not specific for Langerhans cells in the context of LCH.

**Clinical Pearl / High-Yield Fact**
Langerhans cell histiocytosis can present with a wide range of clinical manifestations, from unifocal lesions to systemic involvement, including diabetes insipidus, lytic bone lesions, and respiratory symptoms. A high index of suspicion is required for early diagnosis and treatment.

**Correct Answer:** C. CD68